SARS-CoV-2 is More Severe in Men, Emerging Data Suggests in New Review by Mount Sinai Researchers

This knowledge will lead to better management of COVID-19 in prostate cancer patients and will be indispensable in the current and post-pandemic scenarios.

Research Alert

Newswise — Senior Author:  Ash Tewari, MBBS, MCh, Chair of the Department of Urology at the Mount Sinai Health System, Professor, Urology, Oncological Sciences, Icahn School of Medicine at Mount Sinai

First Author: Dimple Chakravarty, PhD, Assistant Professor, Urology, Icahn School of Medicine at Mount Sinai

Bottom Line: This review summarizes recent developments and research and provides just-in-time considerations of our current understanding in three areas: the epidemiological and biological evidence for gender and/or sex disparity in COVID-19 disease; the potential association between COVID-19 and prostate cancer molecular pathogenesis; and current therapeutic options for COVID-19 patients and, in particular, COVID-19 patients with prostate cancer.

Results:  Data from around the world has confirmed that men face a greater risk of severe illness from COVID-19 than women. Researchers have zeroed in on a possible reason: Androgens—male hormones such as testosterone—appear to boost the virus’ ability to get inside cells. At the same time, a gene known as TMPRSS2 is also highly expressed in both COVID-19 and prostate cancer. In fact, these issues may be related—more androgens could signify greater expression of TMPRSS2 which could create a higher susceptibility to the virus.

Why the Research Is Interesting:  Emerging data suggest that COVID-19 is more severe in men, specifically in the age group at risk for prostate cancer. This knowledge will lead to better management of COVID-19 in prostate cancer patients and will be indispensable in the current and post-pandemic scenarios.

Who: Prostate cancer patients belong to the age group that is more susceptible to SARS-CoV-2 infection and, given their cancer, are at a higher risk of developing severe illness due to a weak immune system. The particular vulnerability of older men to COVID-19 compels us to advocate for routine screening of the disease in prostate cancer patients.

What: Experts are on the trail of a mechanism for this male bias—an effort led by prostate cancer researchers. The study of gender-based and sex-based differences in COVID-19 is a priority, since better understanding of these disparities will help in the development of better therapeutic strategies and vaccines, as well as public health policies.

Conclusions:  COVID-19 affects both sexes, and every age group and ethnicity, albeit to varying degrees. COVID-19 disease burden is disproportionately higher in men, and adverse outcomes are further compounded by older age and comorbidities.

Paper Title:  Sex Differences in SARS-CoV-2 infection rates and the potential link to prostate cancer

Journal: Nature – Communications Biology

Review Article Link: https://doi.org/10.1038/s42003-020-1088-9

Said Mount Sinai's Dr. Ash Tewari:
“For me, as for millions of people around the word, the crisis has been quite personal. First, as a prostate cancer surgeon who also conducts research in basic science and immunology, I became interested in the virus in the earliest days of the pandemic. Then, I contracted the infection myself, became ill, and was hospitalized. The experience has made me all the more convinced that we must come together. It is our obligation as researchers and clinicians to provide rigorous evidence-based knowledge during this global health crisis and to develop therapeutic options to address COVID-19 as the pandemic evolves. The work to combat the virus and prostate cancer is urgent and critical.”

Relevant Social Media handles -
Twitter: @AshTewariMD; @MountsinaiUro; @CommsBio; @nresearchnews Facebook: https://www.facebook.com/ashutosh.tewari
Instagram: ashtewarimd
LinkedIn: https://www.linkedin.com/in/ash-tewari-md-4757b44/

###

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 2852
Newswise: Previously, scientists have determined that entry of SARS-CoV-2 into cells occurs through a receptor on the cell surface, known as ACE2. But the McMaster-Waterloo team has found that the ACE2 receptor is at very low levels in human lung tissue.
Released: 11-Aug-2020 8:40 AM EDT
Previously, scientists have determined that entry of SARS-CoV-2 into cells occurs through a receptor on the cell surface, known as ACE2. But the McMaster-Waterloo team has found that the ACE2 receptor is at very low levels in human lung tissue.
McMaster University

Previously, scientists have determined that entry of SARS-CoV-2 into cells occurs through a receptor on the cell surface, known as ACE2. But the McMaster-Waterloo team has found that the ACE2 receptor is at very low levels in human lung tissue.

Released: 10-Aug-2020 3:45 PM EDT
Vaccine to prevent tuberculosis may help limit spread of COVID-19, Missouri S&T researchers say
Missouri University of Science and Technology

A vaccine developed about a century ago to prevent tuberculosis may also help prevent the transmission of COVID-19, according to two Missouri S&T researchers who examined the spread of COVID-19 among countries that require the vaccine and those that do not.The Missouri S&T researchers analyzed COVID-19-related death and incidence rates among nations that require the BCG (Bacillus Calmette-Guerin) vaccine.

Released: 10-Aug-2020 2:50 PM EDT
Cancer care and screenings must remain a priority during COVID-19
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is committed to safely providing patient care and cancer screenings throughout the novel coronavirus (COVID-19) pandemic.

Released: 10-Aug-2020 2:45 PM EDT
What the rest of the world can learn from South Korea's COVID-19 response
University of Colorado Denver

CU Denver researcher investigates how South Korean policy enabled the country to flatten the curve without economic disaster

Released: 10-Aug-2020 2:35 PM EDT
Tulane researchers studying rise in intimate partner violence amid COVID-19 pandemic
Tulane University

Tulane mental health experts say many of the strategies that are critical to ensuring public health are having a major impact on families experiencing intimate partner violence., also known as IPV.

Released: 10-Aug-2020 2:15 PM EDT
Mouthwashes could reduce the risk of coronavirus transmission
Ruhr-Universität Bochum

Sars-Cov-2 viruses can be inactivated using certain commercially available mouthwashes.

Newswise: Coronavirus transmission risk increases along wildlife supply chains
Released: 10-Aug-2020 2:05 PM EDT
Coronavirus transmission risk increases along wildlife supply chains
PLOS

oronaviruses were detected in a high proportion of bats and rodents in Viet Nam from 2013 to 2014, with an increasing proportion of positive samples found along the wildlife supply chain from traders to large markets to restaurants, according to a study published August 10 in the open-access journal PLOS ONE by Amanda Fine of the Wildlife Conservation Society and colleagues.

Newswise: Portable UV Disinfection Chambers Could Help Address PPE Shortage
Released: 10-Aug-2020 1:55 PM EDT
Portable UV Disinfection Chambers Could Help Address PPE Shortage
Georgia Institute of Technology

Portable disinfection chambers that use ultraviolet (UV) light to inactivate virus particles could allow emergency medical technicians, police officers, healthcare workers, pharmacy technicians, and others to quickly disinfect their personal protective equipment (PPE) as they need it.

Newswise: Artificial intelligence could improve accuracy, efficiency of CT screening for COVID-19 diagnosis
Released: 10-Aug-2020 1:45 PM EDT
Artificial intelligence could improve accuracy, efficiency of CT screening for COVID-19 diagnosis
University of Notre Dame

Researchers at the University of Notre Dame are developing a new technique using artificial intelligence (AI) that would improve CT screening to more quickly identify patients with the coronavirus.


Showing results

110 of 2852

close
2.00276